D-Wave Quantum has spent the past week stacking up announcements that each point in the same direction: quantum optimization finding its way into real-world use. A retuned solver, a fresh developer curriculum, a preliminary cancer-prediction result and a Korean partnership all landed within days of one another. What none of them delivers is a signed order — and that gap is precisely what makes the upcoming third-quarter report the number that matters.
Stride gets quicker, and the fine print matters
At the heart of the technical news is Stride, D-Wave’s hybrid solver. According to company-run benchmarks, the revised version reached better solutions within 15 seconds than its predecessor managed in 120 seconds. Note the wording: not the same answer, faster — better answers, sooner.
That distinction cuts both ways. The comparison is an internal test, reported by D-Wave itself, so it says nothing definitive about how much faster any particular customer workload will run, nor about the economic payoff that might follow. What it does establish is a head-to-head result between two software versions under the conditions D-Wave chose to test.
Alongside the solver upgrade, the company unveiled a three-course learning path aimed at developers working with applied quantum optimization. Pairing better tooling with training is a more meaningful signal for investors than a standalone speed claim. Still, easier access is not the same as broader adoption, and a curriculum launch is no proof of fresh bookings or revenue.
A lab result with a caveat attached
Separate research out of Florida Atlantic University offers a glimpse of where the technology might eventually play. D-Wave’s annealing systems hit 94.31% accuracy in simulation and 91.90% on quantum hardware in work on lung-cancer prediction.
The university and the researchers involved were explicit about the limits. The findings are preliminary and rest on a dataset augmented through data expansion; newly recruited patients did not form the basis of the study. That places the result firmly in the realm of application potential — a world away from a clinically validated tool or a commercial contract. Keeping that line clear is what stops a technical milestone from being mistaken for a business win.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
Korea: a handshake, not a purchase order
Roughly a week ago came a different kind of development: a non-binding memorandum of understanding with LG CNS. The two sides intend to push quantum optimization forward in South Korea and in international markets, with joint marketing opportunities mapped out across manufacturing, telecommunications, financial services and retail. No financial terms were disclosed.
Those sectors describe target markets, not secured customers. An MOU can open doors to possible applications; it cannot be read as a promise of orders. Its value to shareholders sits in the business perspective it creates, not in guaranteed revenue — and it belongs in the “market development” column rather than the “binding contract” one.
November 10 is where the story gets tested
D-Wave plans to publish its third-quarter 2026 results before the market opens on November 10, 2026. That date is the next scheduled moment when the financial picture will sit alongside the technical and strategic headlines.
For investors, the question is how these prospects show up in reported numbers. Research, market entry and firm business each carry a different evidentiary weight: a preliminary finding, an uncommitted intent, a signed order. The announcements so far answer that question only in part — or not at all. Sorting them with that discipline will make the November 10 print far easier to read than simply counting the positive headlines.
Ad
D-Wave Quantum Stock: Buy or Sell?! New D-Wave Quantum Analysis from November 4 delivers the answer:
The latest D-Wave Quantum figures speak for themselves: Urgent action needed for D-Wave Quantum investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 4.
D-Wave Quantum: Buy or sell? Read more here...
